BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7797898)

  • 1. Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome.
    Cossarizza A; Ortolani C; Mussini C; Borghi V; Guaraldi G; Mongiardo N; Bellesia E; Franceschini MG; De Rienzo B; Franceschi C
    J Infect Dis; 1995 Jul; 172(1):105-12. PubMed ID: 7797898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of selective V beta deletion in CD4+ or CD8+ T lymphocytes and functional integrity of T-cell repertoire during acute HIV syndrome.
    Cossarizza A; Ortolani C; Mussini C; Guaraldi G; Mongiardo N; Borghi V; Barbieri D; Bellesia E; Franceschini MG; De Rienzo B
    AIDS; 1995 Jun; 9(6):547-53. PubMed ID: 7662191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viro-immunological studies in acute HIV-1 infection.
    Roos MT; de Leeuw NA; Claessen FA; Huisman HG; Kootstra NA; Meyaard L; Schellekens PT; Schuitemaker H; Miedema F
    AIDS; 1994 Nov; 8(11):1533-8. PubMed ID: 7848590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
    Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
    Giorgi JV; Ho HN; Hirji K; Chou CC; Hultin LE; O'Rourke S; Park L; Margolick JB; Ferbas J; Phair JP
    J Infect Dis; 1994 Oct; 170(4):775-81. PubMed ID: 7930717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
    Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
    Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity.
    Ferbas J; Kaplan AH; Hausner MA; Hultin LE; Matud JL; Liu Z; Panicali DL; Nerng-Ho H; Detels R; Giorgi JV
    J Infect Dis; 1995 Aug; 172(2):329-39. PubMed ID: 7622874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patients.
    Ramzaoui S; Jouen-Beades F; Michot F; Borsa-Lebas F; Humbert G; Tron F
    Clin Exp Immunol; 1995 Feb; 99(2):182-8. PubMed ID: 7851009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen.
    Moss RB; Wallace MR; Giermakowska WK; Webb E; Savary J; Chamberlin-Brandt C; Theofan G; Musil R; Richieri SP; Jensen FC; Carlo DJ
    J Infect Dis; 1999 Sep; 180(3):641-8. PubMed ID: 10438350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of activated T lymphocytes (CD3 + HLA/DR +) detectable in early stages of HIV-1 infection.
    Bogner JR; Matuschke A; Heinrich B; Schreiber MA; Nerl C; Goebel FD
    Klin Wochenschr; 1990 Apr; 68(8):393-6. PubMed ID: 1971856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T lymphocyte subsets, and stage of infection in homosexual men.
    Margolick JB; Farzadegan H; Hoover DR; Saah AJ
    J Infect Dis; 1996 Feb; 173(2):468-71. PubMed ID: 8568314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive infection in a subset of HIV-1-positive chimpanzees.
    O'Neil SP; Novembre FJ; Hill AB; Suwyn C; Hart CE; Evans-Strickfaden T; Anderson DC; deRosayro J; Herndon JG; Saucier M; McClure HM
    J Infect Dis; 2000 Oct; 182(4):1051-62. PubMed ID: 10979899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential impact of CD4+ T cell activation and enhanced Th1/Th2 cytokine ratio on HIV-1 secretion in the lungs of individuals with advanced AIDS and active pulmonary infection.
    Rubbo PA; Tuaillon E; Bolloré K; Foulongne V; Bourdin A; Nagot N; Van de Perre P; Desgranges C; Israël-Biet D; Vendrell JP
    Clin Immunol; 2011 May; 139(2):142-54. PubMed ID: 21345739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of blood CD16/CD56 (NK) and HLA-DR/CD3-positive lymphocyte amounts in HIV-infected children, as related to clinical progression and p24-antigen/p24-antibody presence.
    Voiculescu C; Avramescu C; Balasoiu M; Turculeanu A; Radu E
    FEMS Immunol Med Microbiol; 1994 Sep; 9(3):217-21. PubMed ID: 7529081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated naive and memory CD4+ and CD8+ subsets in different stages of HIV infection.
    Ginaldi L; De Martinis M; D'Ostilio A; Di Gennaro A; Marini L; Profeta V; Quaglino D
    Pathobiology; 1997; 65(2):91-9. PubMed ID: 9253033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.